Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
-
-
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
-
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
High-speed microscope captured fleeting brain signals
On Mar. 19, 2020, University of California, Berkeley, investigators have now built such a camera: a microscope that…
-
Cumberland Pharmaceuticals announced initiative to expand availability of Caldolor to treat fevers associated with Coronavirus Infections
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
-
Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it has significantly expanded its capacity to test clinical samples for…
-
LabCorp sets dedicated hours to serve the non-COVID-19 testing needs for elderly and most vulnerable people
On Mar. 19, 2020, LabCorp announced it is dedicating the first hour of service each day at its…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
-
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
-
Artificial Intelligence | Biotechnology | COVID-19 | FDA | Infectious Disease | Oncology | Pharmaceutical | Therapeutics
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
-
Eli Lilly and Indiana State Department of Health partnered to accelerate COVID-19 testing using Lilly Research Laboratories
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
-
Emergent Biosolutions signed development and manufacturing agreement with Vaxart for experimental Coronavirus oral vaccine
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
-
Nike leaders donated $7 million to support OHSU’s COVID-19 response
On Mar. 18, 2020, Nike CEO John Donahoe and his wife, Eileen, along with Nike Chairman Mark Parker…
-
Heat Biologics collaborated with University of Miami to develop COVID-19 Coronavirus vaccine
On Mar. 18, 2020, Immunology researchers at the University of Miami Miller School of Medicine announced a collaboration…
-
Edmonton company Entos Pharma developing DNA vaccine against COVID-19
On Mar. 18, 2020, Entos Pharmaceuticals, a health-care biotechnology company that develops new therapeutic compounds using the company’s…
-
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
-
CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
-
Israel weighed “compassionate use” of Pluristem therapy for COVID-19
On Mar. 17, 2020, Israel’s Health Ministry announced that it had approved a request by Pluristem Therapeutics to…
-
Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assay
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
MannKind refocuses pipeline resources in response to COVID-19 pandemic
On Mar. 17, 2020, MannKind announced it was adjusting research and development resources that were reserved for its…
-
Genomic analysis showed COVID-19 coronavirus epidemic has a natural origin
On Mar. 17, 2020, scientists reported the novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China,…
-
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
-
BioReference Laboratories and NYC Health + Hospitals announced collaboration to provide Coronavirus testing
On Mar. 17, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the New York City…
-
Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding…
-
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Medical Device | Oncology
Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
-
TGen, a genomic first responder, ramped up testing against COVID-19 coronavirus
On Mar. 17, 2020, acting as Genomic First Responders, The Translational Genomics Research Institute (TGen), an affiliate of…
-
Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
-
Meridian Bioscience supports companies in fighting Coronavirus withg zero cost proprietary technology for evaluation
On Mar. 16, 2020, Meridian Bioscience announced its increased commitment to the global fight against COVID-19 by making…
-
UMN Institute scientist links ancient virus to cancer risk
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
